|
Jun 28
|
Is It Too Late to Buy Iovance Biotherapeutics Stock?
|
|
Jun 10
|
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
|
|
May 16
|
4 Small-Cap Value Stocks That Could Go Parabolic
|
|
May 10
|
Why Iovance Stock Is Down 18% Today
|
|
May 10
|
Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
|
|
May 10
|
Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
|
|
May 10
|
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
|
|
May 9
|
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
|
|
May 6
|
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
|
|
May 6
|
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
|
|
May 1
|
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
|
|
Apr 29
|
With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners
|
|
Apr 28
|
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
|
|
Apr 27
|
The Top 3 Biotech Stocks to Buy in April 2024
|
|
Apr 25
|
3 Millionaire-Maker Biotech Stocks
|
|
Apr 25
|
20 Counties with the Highest Cancer Rates in the US
|
|
Apr 24
|
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
|
|
Apr 21
|
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
|
|
Apr 17
|
Is Iovance Biotherapeutics Stock a Buy Now?
|